articleOphthalmologyMay 1, 2012GREEN OA

Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration

DMDaniel MartínMGMaureen G. MaguireSLStuart L. FineGYGui‐Shuang YingGJGlenn J. Jaffe

Cleveland Eye Clinic · Cleveland Clinic · +5 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,707
total citations
FWCI
164.34
Percentile
100%
References
22
Citations per year

Authors

9

Topics & keywords

Topics
Keywords
  • Medicine
  • Ranibizumab
  • Bevacizumab
  • Macular degeneration
  • Regimen
  • Visual acuity
  • Randomized controlled trial
  • Confidence interval
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.